Clinical Research Institute and Samsung Biomedical Research Institute are performing medical research activities on the advanced treatment and diagnostic technologies to improve health of humankind.
CRI has been established to elevate the level of clinical medicine through systematic research activities, CRI maintains high quality standard in its research teams who carry out SMC’s research projects as well as government project. CRI also operates an advanced system if related information collection and dissemination.
- Tissue Engineering Center
- Clinical Trial Center
- Radiology Research Center
- Cancer Research Center
- Gene Therapy Research Center
- General Laboratories
- Office of Planning & Strategy
Research teams of SBRI, in collaboration with SMC’s faculty staff, is leading biomedical research in Korea in the molecular medicine and clinical medicine. SBRI’s focus research areas include clarification of human immune system cased on molecular biology, genetics, and step clarification of cancer causes towards better knowledge in these areas and development of improved treatment technology. SBRI has secured a close cooperative research ties with Samsung Medical Center And Sungkyunkwan University School of Medicine.
- Molecular Medicine Research Center
- Clinical Medicine Research Center
- Genetic Research Center
The most quoted number of papers as recognized by SCI among all research institutes in Korea. (Ministry of Science & Technology report, 2000)
The highest number of patent applications among all medical centers in Korea – A total of 139 patent applications and 76 patent registrations
Global certifications
- SMC and its IRB are Asia’s First registered Institutes at U.S. OHRP
- U.S. Federal Wide Assurance institution for Clinical Trials
- Asia’s First AAALAC accreditation Institution
- SMC is the first non-US organization to receive full AAHRPP
(Association for Accreditation of Human Research Protection Program)
